AFP and hepatocellular carcinoma: [14] Previous biomarker response studies have evaluated the correlation between plasma angiogenesis biomarkers, alpha-fetoprotein (AFP) level or vascular permeability-perfusion of dynamic magnetic resonance imaging, and responses to sorafenib in patients with advanced HCC.